Orexo to participate in Pareto Securities´ 15th Annual Healthcare Conference 2024
OREXO AB SP/ADR (ORXOY)
NASDAQ:AMEX Investor Relations:
orexo.com/en/investors
Company Research
Source: PR Newswire
UPPSALA, Sweden, Sept. 3, 2024 /PRNewswire/ -- Orexo AB (Publ.), (STO: ORX) (OTCQX: ORXOY), today announces the company will participate in Pareto Securities' 15th Annual Healthcare Conference, that takes place on September 19, at Downtown Camper by Scandic, Brunkebergstorg 9, Stockholm, Sweden.On the day, between 2:25-2:45 CET (room Event Small), Robert Rönn, SVP and Head of R&D, will give a company presentation. Robert Rönn and Lena Wange, Investor Relations, will also be available for 1-1 meetings.For more information, please contact:Orexo AB (publ.)Lena Wange, IR & Communications Director+46 18 780 88 00ir@orexo.comAbout OrexoOrexo is a Swedish pharmaceutical company with nearly 30 years of experience developing improved pharmaceuticals based on proprietary formulation technologies that meet large medical needs. On the US market, Orexo provides innovative treatment solutions for patients suffering from opioid use disorder and adjacent diseases. Products targeting other therapeutic
Show less
Read more
Impact Snapshot
Event Time:
ORXOY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ORXOY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ORXOY alerts
High impacting OREXO AB SP/ADR news events
Weekly update
A roundup of the hottest topics
ORXOY
News
- Orexo initiates new study of OX640 in participants with allergic rhinitis [Yahoo! Finance]Yahoo! Finance
- Orexo initiates new study of OX640 in participants with allergic rhinitisPR Newswire
- Orexo initiates new study of OX640 in participants with allergic rhinitisPR Newswire
- Orexo AB reports Q3 results [Seeking Alpha]Seeking Alpha
- Orexo Interim Report Q3 2024 [Yahoo! Finance]Yahoo! Finance